Paula G. Heller

Buenos Aires, C, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

`Inflammatory mediators differentially regulate megakaryopoiesis and thrombopoiesis in myelofibrosis and essential thrombocythemia.

`Inflammatory mediators differentially regulate megakaryopoiesis and thrombopoiesis in myelofibrosis and essential thrombocythemia.

Journal: Scientific reports

Published: May 26, 2025

Cytoreductive treatment differentially affects platelet size and cytoskeletal megakaryocyte organization during thrombopoiesis in myeloproliferative neoplasms.

Cytoreductive treatment differentially affects platelet size and cytoskeletal megakaryocyte organization during thrombopoiesis in myeloproliferative neoplasms.

Journal: Experimental hematology

Published: April 28, 2025

Acquired Bernard-Soulier syndrome as the presenting feature of GATA2-related myeloid neoplasm in an adolescent: an insight into the mechanisms underlying the platelet defect.

Acquired Bernard-Soulier syndrome as the presenting feature of GATA2-related myeloid neoplasm in an adolescent: an insight into the mechanisms underlying the platelet defect.

Journal: Haematologica

Published: February 13, 2025

Two novel families with RUNX1 variants indicate glycine 168 as a new mutational hotspot: Implications for FPD/AML diagnosis.

Two novel families with RUNX1 variants indicate glycine 168 as a new mutational hotspot: Implications for FPD/AML diagnosis.

Journal: British journal of haematology

Published: July 23, 2024

Elevated levels of damage-associated molecular patterns HMGB1 and S100A8/A9 coupled with toll-like receptor-triggered monocyte activation are associated with inflammation in patients with myelofibrosis.

Elevated levels of damage-associated molecular patterns HMGB1 and S100A8/A9 coupled with toll-like receptor-triggered monocyte activation are associated with inflammation in patients with myelofibrosis.

Journal: Frontiers in immunology

Published: January 03, 2024

Toll-like receptor expression and functional behavior in platelets from patients with systemic lupus erythematosus.

Toll-like receptor expression and functional behavior in platelets from patients with systemic lupus erythematosus.

Journal: Immunobiology

Published: August 04, 2023

High cell-free DNA is associated with disease progression, inflammasome activation and elevated levels of inflammasome-related cytokine IL-18 in patients with myelofibrosis.

High cell-free DNA is associated with disease progression, inflammasome activation and elevated levels of inflammasome-related cytokine IL-18 in patients with myelofibrosis.

Journal: Frontiers in immunology

Published: February 08, 2023

Pathogenic mechanisms contributing to thrombocytopenia in patients with systemic lupus erythematosus.

Pathogenic mechanisms contributing to thrombocytopenia in patients with systemic lupus erythematosus.

Journal: Platelets

Published: November 22, 2021

A Deep Dive into the Pathology of Gray Platelet Syndrome: New Insights on Immune Dysregulation.

A Deep Dive into the Pathology of Gray Platelet Syndrome: New Insights on Immune Dysregulation.

Journal: Journal of blood medicine

Published: March 26, 2021

The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology.

The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 29, 2020

Specifications of the variant curation guidelines for ITGA2B/ITGB3: ClinGen Platelet Disorder Variant Curation Panel.

Specifications of the variant curation guidelines for ITGA2B/ITGB3: ClinGen Platelet Disorder Variant Curation Panel.

Journal: Blood advances

Published: October 29, 2020

First description of revertant mosaicism in familial platelet disorder with predisposition to acute myelogenous leukemia: correlation with the clinical phenotype.

First description of revertant mosaicism in familial platelet disorder with predisposition to acute myelogenous leukemia: correlation with the clinical phenotype.

Journal: Haematologica

Published: July 16, 2020

Showing 1-12 of 48

Last Updated: 09/26/2026